We all need to think about whether the extreme damage that is being done to people's lives by the reaction to the coronavirus isn't worse than the disease itself.
Read More
Another area dealt with extensively in the MedPAC annual report is Medicare Advantage.
Read More
MedPAC's annual report to Congress includes examination of the effects of hospital consolidation and abuses of the 340B program.
Read More
Research in JAMA finds that orders regarding life-sustaining treatment near the end-of-life are often not followed.
Read More
A study in JAMA reveals once again the avaricious pricing behavior of drug companies.
Read More
The latest Altarum Institute briefs on health spending are released, covering the period through the end of last year.
Read More
Research published in JAMA builds on BEA work analyzing spending by disease.
Read More
A study in JAMA discusses the profitability of large drug companies.
Read More
Giving doctors more information about a patient's adherence to prescriptions and access to pharmacist help did not improve adherence to medication regimens.
Read More
Going off topic, in a way, to explore how providing private school options improves pubic schools.
Read More
Drug manufacturer payments to doctors appear to have modest effects on prescribing behavior.
Read More
Research published in Health Services Research suggests that utilization differences among enrollees in high-deductible versus other plan designs is driven by selection issues.
Read More
Yay!! My favorite piece of research, the statistical brief on concentration in health care spending, arrives from AHRQ for 2017.
Read More
A new study indicates that some hospitals have much greater use of consultations during an inpatient stay, with little effect on quality measures.
Read More